LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
41:21
Description
Related Videos
LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
View More
View Less
41:21
LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
Learn how to improve assay robustness and reduce the burden associated with migrating methods downstream in the analysis and monitoring of product quality attributes of biopharmaceuticals.
41:25
Critical to the development of a biosimilar is understanding the originator and how its CQAs compare against the biosimilar. Learn about solutions that provide high quality peptide mapping, glycan and charge variant data.
1:03:24
Join world-renowned Professor Perdita Barran from the Institute of Biotechnology as she shares her incredible research into Parkinson's Disease.
22:49
Learn how Similis Bio implemented a streamlined mAb subunit LC-MS workflow for Multiple Attribute Monitoring of biosimilar mAb candidates during bioprocessing and development.
38:53
Released N-linked glycan analysis is the gold standard for N-glycan profiling of therapeutic monoclonal antibodies (mAbs) as they play an important role in safety and efficacy.
25:51
Here we show how an automation-assisted at-line LC-MS based Process Analytical Technology (PAT) has been successfully implemented to understand process parameters affecting the mis-paired bispecific antibody ratio.
43:22